SummaryNovember 10, 2022 PETACH-TIKVA, ISRAEL – Aposense, an Israeli biotechnology company, with transformational drug delivery technology, announced today that it has received a grant from
The English translation of an interview on Ynet with Prof. Roger Kornberg the scientific president of Aposense and SirVir. Petach Tikva, and Ness-Ziona, Israel. (April
